Bradsaúde (SAUD3) Q1 2026 earnings summary

Executive summary

• Consolidated net income reached R$1.3 billion in 1Q26, with annualized ROAE of 24.8%, and revenues of R$13.4 billion, reflecting strong scale and growth in the healthcare ecosystem.

• The ecosystem serves over 13 million beneficiaries, integrating health and dental insurance, hospitals, clinics, diagnostics, and technology platforms.

• Net additions of 193,000 beneficiaries in the quarter and 710,000 over the past 12 months, driven by commercial synergies and service expansion.

• Major corporate restructuring completed, merging Bradesco Saúde, Odontoprev, and other assets under Bradsaúde, with shares now traded under the SAUD3 ticker.

• Atlântica Hospitais expanded to 3,921 beds, with R$4.8 billion committed to hospital investments.

Financial highlights

• Revenues reached R$13.4 billion in 1Q26, with Bradesco Saúde written premiums up 8.4% year-over-year to R$13.25 billion.

• Net income for 1Q26 was R$1.3 billion, with Bradesco Saúde contributing 83%, Odontoprev 11%, and Atlântica Hospitais 5%.

• Financial assets totaled R$28.6 billion at the end of 1Q26, with financial results of R$875 million.

• Odontoprev net operating revenues grew 4.9% year-over-year to R$619.5 million in 1Q26.

• Net margin remained strong at 20% for the group, with Odontoprev net margin at 24.3% in 1Q26.

Outlook and guidance

• Management remains cautious on claims ratio for 2026 due to seasonality, rising frequency, and medical inflation.

• Ongoing expansion of hospital network with new openings scheduled through 2029, including Santa Lúcia Gama and Albert Einstein Vila Mariana.

• Focus on sustainable cost management, price discipline, and long-term client retention.

• Ongoing investments in technology, digital health, and innovation to enhance customer experience and operational efficiency.

• Strategic consolidation of healthcare businesses under the Bradesco Group is expected to optimize operational efficiency from 2Q26 onward.